Viewing nowCombinationHyperstar Tablet 40/10mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 201607199 · Approved 2016.12.21 · Insurance code 649103210
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with primary hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or telmisartan. This drug effectively lowers blood pressure, reduces the risk of cardiovascular complications, and helps maintain stable blood pressure control.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, a direct switch to this medicine may be considered as follows. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended that treatment be initiated at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, administration of this medicine is not recommended.
This drug should not be used during pregnancy, especially in the second and third trimesters, as it can pose a serious risk to the fetus. If pregnancy is confirmed, use of this medication should be immediately discontinued. This drug should not be administered to patients with specific conditions. For example, it is contraindicated in those with an allergy to any component, pregnant women, nursing mothers, patients with obstructive biliary disease, severe liver dysfunction, patients with heart valve problems, patients with severe hypotension, patients in severe shock, and those with hemodynamic instability after acute myocardial infarction, among others. Additionally, patients with primary aldosteronism, liver dysfunction, active peptic ulcer disease, renal artery hypertension, dialysis patients, and the elderly should use this medication with caution. This medication may cause common side effects such as dizziness and peripheral edema, and severe side effects have been reported infrequently. Therefore, if any unusual symptoms occur during use, it is necessary to consult a healthcare professional immediately. Use during pregnancy is extremely dangerous; thus, if you are planning a pregnancy or are pregnant, it is essential to consult with a physician, and it is also safer not to take this medication while breastfeeding. This drug may interact with other medications, so it is important to inform your doctor of any medications currently being taken, especially when used in conjunction with drugs that can raise potassium levels or cardiovascular medications. Hypotension symptoms may occur if blood pressure drops too low, so patients at risk of hypotension should be carefully monitored and treatment adjustments made as needed. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. Patients with cardiovascular disease should be carefully monitored as excessive blood pressure reduction may increase the risk of myocardial infarction, among other issues. In case of overdose, serious hypotension or cardiac problems may occur, so immediate emergency treatment is necessary, and appropriate treatment should be applied according to the patient's condition. This drug is not recommended for children, as its safety and efficacy have not been adequately confirmed in pediatric patients. When storing, keep this product out of reach of children and to maintain product quality, it should be opened just before use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that blocks light, as it may be light-sensitive. It is also best to store the medication at room temperature between 1 to 30 degrees Celsius. By doing so, the drug’s effectiveness can be maintained, and safe use can be ensured.
This is a white and light gray, double convex, oval-shaped tablet.
30 tablets (10 tablets/AluAlu X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.